血管通路手术市场－全球产业规模、份额、趋势、机会及预测（依手术类型、应用、地区及竞争格局划分，2020-2030 年预测）

2024 年全球血管通路程序市场价值为 913.5 亿美元，预计到 2030 年将达到 1,252.8 亿美元，复合年增长率为 5.38%。由于医疗保健需求不断增长以及慢性病负担加重，全球血管通路程序市场正在大幅扩张。血管通路程序包括插入中心静脉导管、经週边插入中心静脉导管 (PICC) 和动静脉瘻管等设备，对于给药、营养、透析和血液采样至关重要。癌症、肾臟疾病和心血管疾病等慢性病入院人数的增加导致对高效和长期血管通路解决方案的需求相应激增。全球人口老化，更容易患上需要定期医疗干预的合併症，也导致程序数量增加。手术量的增加、住院时间的延长以及对使用便携式输液设备进行家庭护理的偏好的增加，正在加速市场对安全、可靠且易于插入的血管通路设备的需求。

市场也受到显着的技术创新和趋势的影响。导管材料和设计的进步，例如抗菌涂层和超音波引导插入技术，正在减少感染和血栓形成等併发症。影像和导航技术与血管通路手术的整合，使器械置入更加精准，并降低了插入失败率。向微创通路技术的转变正在获得关注，尤其是在门诊和流动医疗环境中，这提高了患者的舒适度并降低了医疗成本。市场参与者正致力于推出使用者友善且经济高效的器械，以满足高容量医院和低资源环境的需求。加强医疗服务提供者对器械选择和插入方案的培训和意识，正在进一步提高手术成功率和病人安全性。

儘管全球血管通路程序市场呈现正面势头，但仍面临诸多挑战。先进血管通路设备和程序的高昂成本可能会限制其在低收入或资源受限地区的应用。导管相关性血流感染 (CRBSI)、阻塞和机械故障等设备相关併发症持续构成重大临床风险。不同医疗机构的临床医生技能水平参差不齐以及缺乏标准化的插入技术，往往导致患者治疗结果不一致。新型血管通路设备审批的严格监管要求可能会延迟产品上市并阻碍创新。此外，对设备耐用性、频繁更换和患者不适的担忧可能会阻碍某些患者群体采用这些设备。透过改进培训、针对患者设计的设备以及持续的临床研究来应对这些挑战，对于确保市场可持续成长至关重要。

关键市场驱动因素

需要长期血管通路的慢性疾病盛行率不断上升

主要市场挑战

血管通路装置相关併发症风险高

主要市场趋势

影像导引血管通路技术的应用日益广泛

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球血管通路手术市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依手术（动静脉瘻管、动静脉移植、中心静脉导管、其他）
  • 依应用（化疗、血液透析、输血、静脉抗生素治疗、其他）
  • 按公司分类（2024）
  • 按地区
• 市场地图

第六章：北美血管通路程序市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 墨西哥
  • 加拿大

第七章：欧洲血管通路程序市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太血管通路手术市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲

第九章：南美洲血管通路程序市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲血管通路程序市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如有）
• 最新动态

第十三章：干扰：衝突、流行病与贸易壁垒

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 15 章：竞争格局

• Teleflex Incorporated
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Cook Group Incorporated
• AngioDynamics, Inc.
• Medtronic plc
• Medical Components, Inc.
• Terumo Corporation
• Access Vascular, Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

Global Vascular Access Procedures Market was valued at USD 91.35 Billion in 2024 and is expected to reach USD 125.28 Billion by 2030 with a CAGR of 5.38%. The Global Vascular Access Procedures Market is witnessing substantial expansion as a result of increasing healthcare demands and the growing burden of chronic illnesses. Vascular access procedures, which include the insertion of devices such as central venous catheters, peripherally inserted central catheters (PICCs), and arteriovenous fistulas, are critical for administering medications, nutrition, dialysis, and for blood sampling. A rise in hospital admissions for chronic conditions like cancer, kidney disease, and cardiovascular ailments has led to a corresponding surge in the need for efficient and long-term vascular access solutions. The aging global population, which is more prone to comorbidities requiring regular medical interventions, is also contributing to higher procedure volumes. Rising surgical volumes, longer hospital stays, and increasing preferences for home-based care with portable infusion devices are accelerating the market demand for safe, reliable, and easy-to-insert vascular access devices.

The market is also shaped by notable technological innovations and trends. Advancements in catheter materials and designs, such as antimicrobial coatings and ultrasound-guided insertion techniques, are reducing complications such as infections and thrombosis. The integration of imaging and navigation technologies into vascular access procedures is making device placement more accurate and reducing the rate of failed insertions. A shift toward minimally invasive access techniques is gaining traction, particularly in outpatient and ambulatory settings, leading to improved patient comfort and reduced healthcare costs. Market participants are focusing on launching user-friendly and cost-effective devices that cater to both high-volume hospitals and low-resource settings. Increasing training and awareness among healthcare providers regarding device selection and insertion protocols is further improving procedural success rates and patient safety.

Despite the positive momentum, several challenges persist in the Global Vascular Access Procedures Market. High costs associated with advanced vascular access devices and procedures can limit their adoption in lower-income or resource-constrained settings. Device-related complications such as catheter-related bloodstream infections (CRBSIs), occlusions, and mechanical failures continue to pose significant clinical risks. Variability in clinician skill levels and lack of standardized insertion techniques across facilities often result in inconsistent patient outcomes. Stringent regulatory requirements for the approval of new vascular access devices may delay product launches and hinder innovation. Moreover, concerns over device durability, frequent replacements, and patient discomfort may discourage adoption in some patient populations. Addressing these challenges through improved training, patient-specific device design, and ongoing clinical studies will be crucial in ensuring sustainable market growth.

Key Market Drivers

Growing Prevalence of Chronic Diseases Requiring Long-term Vascular Access

The growing prevalence of chronic diseases that require long-term vascular access is one of the most significant drivers of the Global Vascular Access Procedures Market. Chronic kidney disease (CKD) alone affects more than 800 million people globally, accounting for over 10% of the world's population, and its prevalence continues to increase, especially in low- and middle-income countries due to rising rates of diabetes and hypertension. A large proportion of CKD patients depend on hemodialysis, which demands reliable vascular access methods such as arteriovenous fistulas, grafts, and central venous catheters. These access points are critical for ensuring efficient dialysis sessions and improving patient survival outcomes.

Cancer incidence is another major factor contributing to market growth. In 2022, there were nearly 20 million new cancer cases and about 9.7 million deaths worldwide. Many cancer patients undergo chemotherapy, targeted therapy, and supportive treatments requiring long-term intravenous access through devices like implantable ports or peripherally inserted central catheters (PICCs). In parallel, the burden of severe infections and sepsis remains extremely high, with 48.9 million cases and 11 million related deaths annually, representing one in every five deaths globally. These cases frequently necessitate prolonged antibiotic administration via secure vascular access devices.

Technological advancements have further strengthened the role of vascular access procedures in chronic disease management. The introduction of antimicrobial-coated catheters, ultrasound-guided insertion techniques, and needle-free connectors has improved safety, reduced infection risks, and extended device longevity. Growing awareness among healthcare providers about early vascular access planning, especially for patients with progressive chronic illnesses, is improving treatment efficiency and patient quality of life. With aging populations and rising comorbidity rates, demand for dependable, long-term vascular access solutions is expected to accelerate, driving substantial market expansion in the years ahead.

Key Market Challenges

High Risk of Complications Associated with Vascular Access Devices

The Global Vascular Access Procedures Market faces a significant challenge due to the high risk of complications associated with vascular access devices, which can impact patient outcomes and limit procedural adoption. Complications such as catheter-related bloodstream infections (CRBSIs), thrombosis, stenosis, hematoma formation, and device malfunction are common concerns that can arise during or after the procedure. Infections remain one of the most critical risks, as they not only lead to increased morbidity but also escalate healthcare costs due to prolonged hospital stays, additional treatments, and the need for device replacement. Thrombosis and stenosis can compromise the efficiency of vascular access, requiring repeat interventions that increase the burden on both healthcare systems and patients. In certain cases, repeated procedures can lead to limited viable access sites, especially in patients undergoing long-term treatments like hemodialysis or chemotherapy.

The risk of complications is amplified in patients with multiple comorbidities, weakened immune systems, or poor vascular health, making device placement and maintenance more challenging. A lack of standardized training protocols for device insertion and maintenance in some regions contributes to procedural variability, which can further elevate complication rates. Concerns about these risks often lead to hesitancy among healthcare providers and patients, slowing adoption of advanced vascular access solutions despite their potential benefits. This challenge necessitates continuous innovation in device design, incorporation of antimicrobial coatings, and the implementation of strict infection control protocols. Without addressing these safety concerns effectively, market growth may be hindered due to the potential for adverse events that undermine trust in vascular access procedures.

Key Market Trends

Rising Adoption of Image-Guided Vascular Access Techniques

The Global Vascular Access Procedures Market is witnessing a notable trend with the rising adoption of image-guided vascular access techniques, driven by the growing demand for precision, safety, and efficiency in medical interventions. Image-guided procedures, using ultrasound, fluoroscopy, or other imaging modalities, allow clinicians to visualize the vascular anatomy in real time, significantly reducing the risk of complications such as arterial puncture, hematoma, or catheter misplacement. This approach is particularly valuable in complex patient cases, including those with challenging vascular anatomy, pediatric patients, and individuals requiring repeated access for treatments like dialysis or chemotherapy. The integration of imaging technologies into vascular access workflows is improving first-attempt success rates, minimizing patient discomfort, and reducing procedure time, which enhances both clinical outcomes and operational efficiency in healthcare settings.

Technological advancements in portable and handheld ultrasound devices are expanding the accessibility of image-guided procedures beyond specialized centers to community hospitals and outpatient clinics. This trend is also supported by growing clinical evidence demonstrating superior safety profiles and long-term patency rates when image guidance is employed. Training initiatives and skill development programs by medical societies and device manufacturers are equipping healthcare professionals with the expertise to adopt these techniques more widely. As healthcare systems prioritize patient safety, cost-effectiveness, and adherence to evidence-based practices, the shift toward image-guided vascular access is becoming a standard of care across multiple therapeutic areas, positioning it as a critical driver of procedural evolution in the market.

Key Market Players

• Teleflex Incorporated
• Becton, Dickinson and Company
• B. Braun Melsungen AG
• ICU Medical, Inc.
• Cook Group Incorporated
• AngioDynamics, Inc.
• Medtronic plc
• Medical Components, Inc.
• Terumo Corporation
• Access Vascular, Inc.

Report Scope:

In this report, the Global Vascular Access Procedures Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vascular Access Procedures Market, By Procedure:

• Arteriovenous Fistulas
• Arteriovenous Grafts
• Central Venous Catheters
• Others

Vascular Access Procedures Market, By Application:

• Chemotherapy
• Hemodialysis
• Blood Transfusions
• Intravenous Antibiotics Treatment
• Others

Vascular Access Procedures Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vascular Access Procedures Market.

Available Customizations:

Global Vascular Access Procedures Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Vascular Access Procedures Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Procedure (Arteriovenous Fistulas, Arteriovenous Grafts, Central Venous Catheters, Others)
  • 5.2.2. By Application (Chemotherapy, Hemodialysis, Blood Transfusions, Intravenous Antibiotics Treatment, Others)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Vascular Access Procedures Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Procedure
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vascular Access Procedures Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Procedure
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Vascular Access Procedures Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Procedure
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Vascular Access Procedures Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Procedure
      • 6.3.3.2.2. By Application

7. Europe Vascular Access Procedures Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Procedure
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Vascular Access Procedures Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Procedure
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Vascular Access Procedures Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Procedure
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Vascular Access Procedures Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Procedure
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Vascular Access Procedures Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Procedure
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Vascular Access Procedures Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Procedure
      • 7.3.5.2.2. By Application

8. Asia-Pacific Vascular Access Procedures Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Procedure
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vascular Access Procedures Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Procedure
      • 8.3.1.2.2. By Application
  • 8.3.2. India Vascular Access Procedures Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Procedure
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Vascular Access Procedures Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Procedure
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Vascular Access Procedures Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Procedure
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Vascular Access Procedures Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Procedure
      • 8.3.5.2.2. By Application

9. South America Vascular Access Procedures Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Procedure
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vascular Access Procedures Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Procedure
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Vascular Access Procedures Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Procedure
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Vascular Access Procedures Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Procedure
      • 9.3.3.2.2. By Application

10. Middle East and Africa Vascular Access Procedures Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Procedure
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vascular Access Procedures Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Procedure
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Vascular Access Procedures Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Procedure
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Vascular Access Procedures Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Procedure
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Teleflex Incorporated
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Becton, Dickinson and Company
• 15.3. B. Braun Melsungen AG
• 15.4. ICU Medical, Inc.
• 15.5. Cook Group Incorporated
• 15.6. AngioDynamics, Inc.
• 15.7. Medtronic plc
• 15.8. Medical Components, Inc.
• 15.9. Terumo Corporation
• 15.10. Access Vascular, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer